Vitamin D supplementation compared to placebo in people with First Episode psychosis - Neuroprotection Design (DFEND): a protocol for a randomised, double-blind, placebo-controlled, parallel-group trial

BACKGROUND: People experiencing their first episode of psychosis are often deficient in vitamin D. Observational studies have reported an association between low vitamin D concentrations and poorer subsequent health outcomes in psychosis. A vitamin D deficiency in neonates and children has been link...

詳細記述

保存先:
書誌詳細
出版年:Trials
主要な著者: Gaughran, Fiona, Stringer, Dominic, Berk, Michael, Smith, Shubulade, Taylor, David, Whiskey, Eromona, Landau, Sabine, Murray, Robin, McGuire, Philip, Gardner-Sood, Poonam, Wojewodka, Gabriella, Ciufolini, Simone, Jordan, Harriet, Clarke, Jessie, Allen, Lauren, Krivoy, Amir, Stubbs, Brendon, Lowe, Philippa, Arbuthnott, Maurice, Rathod, Shanaya, Boardman, Andrew, Firdosi, Mudasir, McGrath, John J.
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2020
主題:
Study Protocol
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6945550/
https://ncbi.nlm.nih.gov/pubmed/31907006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-019-3758-9
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料